View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsPuriflOH 将来の成長Future 基準チェック /06現在、 PuriflOHの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Water Utilities 収益成長10.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 13PuriflOH Limited, Annual General Meeting, Nov 30, 2022PuriflOH Limited, Annual General Meeting, Nov 30, 2022.お知らせ • Aug 31PuriflOH Limited Announces Positive Test Results on its New Generation of Neutralizer Free Air PurifiersThis technical update provides perspective and explanation to the results of independent performance testing conducted on behalf of PuriflOH Limited on its new generation of neutralizer free Air Purifiers. The work was conducted by Co-Labs of Brunswick, Victoria. Co-Labs is a Bio-safety Level 2 Laboratory that has recently installed a 75 cubic meter bio-aerosol testing chamber and is capable of testing various microbial organisms on surface or air using internationally accepted methods and equipment. Thus far, PuriflOH's approach on air purification has been to provide a single stage technology that can eliminate all air pollutants such as particles, odour, Volatile Organic Compounds (VOCs) and air-borne microbes. PuriflOH, initially through its research partner Somnio Global, and now operating through its own auspices, have continued to develop the Free Radical Generator (FRG)-based air purifiers. The new generation is now more powerful with a higher single-pass kill rate the factor of destruction of microbes between outlet and inlet of an air purifier. Existing products require 3-6 stages of filtration to achieve the same effectiveness. This is a significant and unique improvement over current air purification solutions. Since 2018, Somnio and PuriflOH have engaged with OEM companies in order for them to integrate versions of the Free Radical Generator (FRG) into existing designs to significantly enhance product performance. This OEM engagement has lead to useful market feedback and design changes. For example, the high concentration of radicals needed to significantly remove VOCs and other contaminants efficiently has necessitated neutralizer filters, which add to the overall size of the end product and cost as an air purifier. A result of the Covid-19 pandemic has been that market priorities have shifted to highlight microbial decontamination above all else. This has led to the company focusing its efforts on the Air Conditioner Remediation and Environmental Treatment (ACERT) device as its first commercial product and re- evaluating the design of its air purifiers. Recently, PuriflOH has been actively developing a low-power FRG addition to Air Purifiers, FRG+, that are simple to implement whilst providing significant benefits to the final product. The result of this approach is a new generation of Air Purifiers empowered by the FRG. This newly designed FRG module has the following performance features: An improvement of at least 150% in the speed and efficacy of air purification over current market leading devices. Safe operation in occupied spaces without the need for neutralizer filters. Only 10W of added power consumption. Reducing noise levels in existing air purifiers while improving efficacy. Independent testing and results: PuriflOH has concluded its first independent test on this new FRG+ version of an Air Purifier, conducted at Co-Labs Melbourne, which houses the world's largest and Australia's first Bio-aerosol testing chamber. The test was conducted with Staphylococcus epidermidis, a vegetative bacterium that is analogous to MRSA, a common hospital-acquired infection frequently used in testing disinfectant efficacies. PuriflOH's previous aerosol testing results were obtained from ARE Labs in the USA and performed in a chamber sized 15 cubic metres. The airflow rate of the "Bluemist" device provided for more than 12 air changes per hour in this previously tested chamber. In the test conducted at Co-labs, the chamber volume was 5 times larger (75 m3) and the flow rate allowed for only 5 air changes every hour. Smaller air changes typically increase the time taken to achieve total disinfection. This air exchange rate of 5 per hour is similar to how ventilation and air purification systems are configured in the real world. Despite the larger chamber size and the lower exchange rate, the new FRG+ device was able to achieve 99% reduction in airborne bacteria in approximately 30 mins, at least 1.5 times faster than a standard HEPA based air purifier acting under the same conditions. Moreover, ozone levels in the chamber were tested to remain well within acceptable values, allowing the device to be used in occupied spaces. Commercial impact of new design This new format of the FRG has been designed to incorporate a simple manufacturing and installation process that should increase chances of commercial success. The new design also creates new opportunities for PuriflOH and removes existing obstacles as: This design is highly cost effective and significantly upgrades the efficacy of air purifiers. The design is suitable for businesses, offering a highly effective solution with low operational expenses such as maintenance and power consumption. The FRG is now a retrofit solution to existing air purifiers. The design is easily adaptable to any existing residential or commercial air purifier, thereby making it a very easy OEM solution. PuriflOH will continue to seek internal and external validation of FRG+ Air Purifiers on a roster of challenge organisms including viruses and fungal/bacterial spores, while driving the development towards improved performance in occupied spaces without the need for neutralizer filters.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Mar 31Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be €0.64, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% over the last 3 years. Earnings per share has grown by 9.8%.Buying Opportunity • Mar 15Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 53%. The fair value is estimated to be AU$0.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% per annum over the last 3 years. Earnings per share has grown by 9.8% per annum over the last 3 years.Board Change • Nov 02Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Executive Departure • Apr 25Independent Non-Executive Director has left the companyOn the 22nd of April, Pravansu Mohanty's tenure as Independent Non-Executive Director ended after 1.4 years in the role. We don't have any record of a personal shareholding under Pravansu's name. A total of 2 executives have left over the last 12 months.Is New 90 Day High Low • Mar 06New 90-day low: €0.65The company is down 21% from its price of €0.82 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 3.0% over the same period.Is New 90 Day High Low • Feb 02New 90-day low: €0.66The company is down 33% from its price of €0.98 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is flat over the same period.Is New 90 Day High Low • Jan 06New 90-day low: €0.75The company is down 14% from its price of €0.88 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.お知らせ • Oct 29PuriflOH Ltd Announces Appointment of Jonathon (Jon) Evans as a DirectorPuriflOH Ltd. announced the appointment of Mr. Jonathon (Jon) Evans as a Director of PuriflOH, effective as of 29 October 2020. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific- an Australian/US Health Commercialisation company and most recently as Managing Director, APAC Health Solutions Group. Mr. Evans is also chairman of CEMTAS Australia.Is New 90 Day High Low • Sep 28New 90-day low: €0.68The company is down 55% from its price of €1.49 on 30 June 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.お知らせ • Sep 18PuriflOH Limited Announces Management ChangesPurifloh Limited ("PuriflOH" or "Company") announced the resignation of the Chairman Mr. Bill Parfet, with immediate effect. Mr. Parfet resigns as both Chairman and Director of the Board. The Company's major shareholder, Dilato Holdings Pty Ltd, is controlled by Purifloh director, Mr. Carl Le Souef, who will take up the role of Chairman on an interim basis. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、PuriflOH は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:WXV - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20220000N/A9/30/20220000N/A6/30/202200-1-1N/A3/31/20220000N/A12/31/20210-100N/A9/30/20210-2-1-1N/A6/30/2021N/A-3-2-2N/A3/31/2021N/A-4-4-4N/A12/31/2020N/A-5-5-5N/A9/30/2020N/A-5-5-5N/A6/30/2020N/A-5-4-4N/A3/31/2020N/A-4-4-4N/A12/31/2019N/A-4-4-4N/A9/30/2019N/A-4-3-3N/A6/30/2019N/A-3-3-3N/A3/31/2019N/A-3-2-2N/A12/31/2018N/A-2-2-2N/A9/30/2018N/A-1-1-1N/A6/30/2018N/A-1-1-1N/A3/31/2018N/A000N/A12/31/2017N/A000N/A9/30/2017N/A000N/A6/30/2017N/A000N/A3/31/2017N/A000N/A12/31/2016N/A-100N/A9/30/2016N/A-1N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: WXVの予測収益成長が 貯蓄率 ( 0.2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: WXVの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: WXVの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: WXVの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: WXVの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: WXVの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YUtilities 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/05/14 21:26終値2023/02/14 00:00収益2022/12/31年間収益2022/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PuriflOH Limited これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 13PuriflOH Limited, Annual General Meeting, Nov 30, 2022PuriflOH Limited, Annual General Meeting, Nov 30, 2022.
お知らせ • Aug 31PuriflOH Limited Announces Positive Test Results on its New Generation of Neutralizer Free Air PurifiersThis technical update provides perspective and explanation to the results of independent performance testing conducted on behalf of PuriflOH Limited on its new generation of neutralizer free Air Purifiers. The work was conducted by Co-Labs of Brunswick, Victoria. Co-Labs is a Bio-safety Level 2 Laboratory that has recently installed a 75 cubic meter bio-aerosol testing chamber and is capable of testing various microbial organisms on surface or air using internationally accepted methods and equipment. Thus far, PuriflOH's approach on air purification has been to provide a single stage technology that can eliminate all air pollutants such as particles, odour, Volatile Organic Compounds (VOCs) and air-borne microbes. PuriflOH, initially through its research partner Somnio Global, and now operating through its own auspices, have continued to develop the Free Radical Generator (FRG)-based air purifiers. The new generation is now more powerful with a higher single-pass kill rate the factor of destruction of microbes between outlet and inlet of an air purifier. Existing products require 3-6 stages of filtration to achieve the same effectiveness. This is a significant and unique improvement over current air purification solutions. Since 2018, Somnio and PuriflOH have engaged with OEM companies in order for them to integrate versions of the Free Radical Generator (FRG) into existing designs to significantly enhance product performance. This OEM engagement has lead to useful market feedback and design changes. For example, the high concentration of radicals needed to significantly remove VOCs and other contaminants efficiently has necessitated neutralizer filters, which add to the overall size of the end product and cost as an air purifier. A result of the Covid-19 pandemic has been that market priorities have shifted to highlight microbial decontamination above all else. This has led to the company focusing its efforts on the Air Conditioner Remediation and Environmental Treatment (ACERT) device as its first commercial product and re- evaluating the design of its air purifiers. Recently, PuriflOH has been actively developing a low-power FRG addition to Air Purifiers, FRG+, that are simple to implement whilst providing significant benefits to the final product. The result of this approach is a new generation of Air Purifiers empowered by the FRG. This newly designed FRG module has the following performance features: An improvement of at least 150% in the speed and efficacy of air purification over current market leading devices. Safe operation in occupied spaces without the need for neutralizer filters. Only 10W of added power consumption. Reducing noise levels in existing air purifiers while improving efficacy. Independent testing and results: PuriflOH has concluded its first independent test on this new FRG+ version of an Air Purifier, conducted at Co-Labs Melbourne, which houses the world's largest and Australia's first Bio-aerosol testing chamber. The test was conducted with Staphylococcus epidermidis, a vegetative bacterium that is analogous to MRSA, a common hospital-acquired infection frequently used in testing disinfectant efficacies. PuriflOH's previous aerosol testing results were obtained from ARE Labs in the USA and performed in a chamber sized 15 cubic metres. The airflow rate of the "Bluemist" device provided for more than 12 air changes per hour in this previously tested chamber. In the test conducted at Co-labs, the chamber volume was 5 times larger (75 m3) and the flow rate allowed for only 5 air changes every hour. Smaller air changes typically increase the time taken to achieve total disinfection. This air exchange rate of 5 per hour is similar to how ventilation and air purification systems are configured in the real world. Despite the larger chamber size and the lower exchange rate, the new FRG+ device was able to achieve 99% reduction in airborne bacteria in approximately 30 mins, at least 1.5 times faster than a standard HEPA based air purifier acting under the same conditions. Moreover, ozone levels in the chamber were tested to remain well within acceptable values, allowing the device to be used in occupied spaces. Commercial impact of new design This new format of the FRG has been designed to incorporate a simple manufacturing and installation process that should increase chances of commercial success. The new design also creates new opportunities for PuriflOH and removes existing obstacles as: This design is highly cost effective and significantly upgrades the efficacy of air purifiers. The design is suitable for businesses, offering a highly effective solution with low operational expenses such as maintenance and power consumption. The FRG is now a retrofit solution to existing air purifiers. The design is easily adaptable to any existing residential or commercial air purifier, thereby making it a very easy OEM solution. PuriflOH will continue to seek internal and external validation of FRG+ Air Purifiers on a roster of challenge organisms including viruses and fungal/bacterial spores, while driving the development towards improved performance in occupied spaces without the need for neutralizer filters.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary & Independent Non Executive Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Mar 31Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 27%. The fair value is estimated to be €0.64, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% over the last 3 years. Earnings per share has grown by 9.8%.
Buying Opportunity • Mar 15Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 53%. The fair value is estimated to be AU$0.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 162% per annum over the last 3 years. Earnings per share has grown by 9.8% per annum over the last 3 years.
Board Change • Nov 02Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Company Secretary, Executive Director of Corporate & Independent Director Simon Lill was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Executive Departure • Apr 25Independent Non-Executive Director has left the companyOn the 22nd of April, Pravansu Mohanty's tenure as Independent Non-Executive Director ended after 1.4 years in the role. We don't have any record of a personal shareholding under Pravansu's name. A total of 2 executives have left over the last 12 months.
Is New 90 Day High Low • Mar 06New 90-day low: €0.65The company is down 21% from its price of €0.82 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 3.0% over the same period.
Is New 90 Day High Low • Feb 02New 90-day low: €0.66The company is down 33% from its price of €0.98 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is flat over the same period.
Is New 90 Day High Low • Jan 06New 90-day low: €0.75The company is down 14% from its price of €0.88 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.
お知らせ • Oct 29PuriflOH Ltd Announces Appointment of Jonathon (Jon) Evans as a DirectorPuriflOH Ltd. announced the appointment of Mr. Jonathon (Jon) Evans as a Director of PuriflOH, effective as of 29 October 2020. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific- an Australian/US Health Commercialisation company and most recently as Managing Director, APAC Health Solutions Group. Mr. Evans is also chairman of CEMTAS Australia.
Is New 90 Day High Low • Sep 28New 90-day low: €0.68The company is down 55% from its price of €1.49 on 30 June 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 4.0% over the same period.
お知らせ • Sep 18PuriflOH Limited Announces Management ChangesPurifloh Limited ("PuriflOH" or "Company") announced the resignation of the Chairman Mr. Bill Parfet, with immediate effect. Mr. Parfet resigns as both Chairman and Director of the Board. The Company's major shareholder, Dilato Holdings Pty Ltd, is controlled by Purifloh director, Mr. Carl Le Souef, who will take up the role of Chairman on an interim basis.